Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001928499 | SCV002183742 | uncertain significance | 3-hydroxy-3-methylglutaryl-CoA synthase deficiency | 2021-12-02 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with HMGCS2-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). This variant is present in population databases (rs766097440, gnomAD 0.01%). This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 392 of the HMGCS2 protein (p.Ser392Leu). |
Juno Genomics, |
RCV001928499 | SCV005416837 | likely pathogenic | 3-hydroxy-3-methylglutaryl-CoA synthase deficiency | criteria provided, single submitter | clinical testing | PM2_Supporting+PS3+PM3 |